Simian virus 40 infection in humans and association with human diseases: results and hypotheses (Q34305045)

1 August 2017

1 reference

title

Simian virus 40 infection in humans and association with human diseases: results and hypotheses (English)

1 reference

1 August 2017

Simian virus 40

1 reference

1 reference

Giuseppe Barbanti-Brodano

1

1 reference

1 August 2017

Silvia Sabbioni

2

1 reference

1 August 2017

Fernanda Martini

3

1 reference

1 August 2017

Massimo Negrini

4

1 reference

1 August 2017

Alfredo Corallini

5

1 reference

1 August 2017

Mauro Tognon

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

318

1 reference

1 August 2017

1

1 reference

1 August 2017

1-9

1 reference

Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Cell and molecular biology of simian virus 40: implications for human infections and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Evidence of SV40 infections in hospitalized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Wnt signaling: a common theme in animal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 infection in lymphoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus-40 large-T antigen binds p53 in human mesotheliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40, poliovaccines and human tumors: a review of recent developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 and human brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 is present in human lymphomas and normal blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Lack of serological evidence for an association between simian virus 40 and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Absence of simian virus 40 in human brain tumors from northern India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Virology. Monkey virus link to cancer grows stronger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Public health. Creeping consensus on SV40 and polio vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 infection induces telomerase activity in human mesothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Overexpression of simian virus 40 small-T antigen blocks centrosome function and mitotic progression in human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian Virus 40 Infection of Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Identification in human brain tumors of DNA sequences specific for SV40 large T antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Oncogenic transformation by the human polyomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Prospects for an SV40 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Serological evidence of SV40 infections in HIV-infected and HIV-negative adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Association of SV40 with human tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Association of SV40 with human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Genetic instabilities in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

BK virus and SV40 co-infection in polyomavirus nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Molecular identification of SV40 infection in human subjects and possible association with kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human brain tumors and simian virus 40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Integration of SV40 in human osteosarcoma DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Long-Term Follow-up of Persons Inadvertently Inoculated with SV40 as Neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Amplification of papovavirus defectives during serial low multiplicity infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40-like DNA sequences in human papillary thyroid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Monkey virus DNA found in rare human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Role of T antigen interactions with p53 in tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human polyoma virus-associated interstitial nephritis in the allograft kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 and the pathogenesis of mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The role of the SV40 ST antigen in cell growth promotion and transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Transforming functions of Simian Virus 40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Induction of mutations within the host cell genome by partially inactivated herpes simplex virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Does SV40 infection contribute to the development of human cancers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human exposure to SV40: review and comment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 Neutralizing Antibodies in Sera of US Residents without History of Polio Immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Multiplication and cytopathogenicity of Simian vacuolating virus 40 in cultures of human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Presence of simian virus 40 DNA sequences in human lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

SV40 large T antigen functions in DNA replication and transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans A Renee Stewart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Detection of SV40 T antigen genome in human gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

The vacuolating virus, S.V. 40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Investigation of the simian polyomavirus SV40 as a potential causative agent of human neurological disorders in AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Sewage yields clues to SV40 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Association between simian virus 40 and non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Conventional epidemiology and the link between SV40 and human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Beta-catenin: a key mediator of Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

7 January 2021

Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

7 January 2021

Excretion of Vacuolating SV-40 Virus (Papova Virus Group) After Ingestion as a Contaminant of Oral Poliovaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

7 January 2021

Neutralizing antibodies to simian virus 40 (SV40) in human sera from India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.09.004

7 January 2021

10.1016/J.VIROL.2003.09.004

Identifiers

DOI

1 reference

1 August 2017

1 reference